Ciaffoni Joseph has filed 29 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 79976 shares of Indivior Pharmaceuticals, Inc. ($INDV) on February 10, 2026.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Ciaffoni Joseph | Chief Executive Officer | A | Common Stock | 79976 | $0.00 | 135,976.0000 | 125,000,000 | 142.81% | 0.06% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | A | Common Stock | 179734 | $0.00 | 573,734.0000 | 41,279,981 | 45.62% | 0.44% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | F | Common Stock | 47445 | $33.70 | 526,289.0000 | 41,279,981 | 8.27% | 0.11% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | F | Common Stock | 81422 | $33.70 | 444,867.0000 | 41,279,981 | 15.47% | 0.20% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | A | Common Stock | 119000 | $0.00 | 394,000.0000 | 41,279,981 | 43.27% | 0.29% |
| Dec. 21, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 4357 | $30.38 | 275,000.0000 | 42,058,821 | 1.56% | 0.01% |
| Dec. 21, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 4357 | $0.00 | 16,875.0000 | 42,058,821 | 20.52% | 0.01% |
| Dec. 21, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Common Stock | 4357 | $21.34 | 279,357.0000 | 42,058,821 | 1.58% | 0.01% |
| Dec. 18, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 27798 | $30.04 | 275,000.0000 | 42,058,821 | 9.18% | 0.07% |
| Dec. 19, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Common Stock | 14516 | $21.34 | 289,516.0000 | 42,058,821 | 5.28% | 0.03% |
| Dec. 19, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 14516 | $30.03 | 275,000.0000 | 42,058,821 | 5.01% | 0.03% |
| Dec. 20, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Common Stock | 26454 | $21.34 | 301,454.0000 | 42,058,821 | 9.62% | 0.06% |
| Dec. 20, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 26454 | $30.40 | 275,000.0000 | 42,058,821 | 8.78% | 0.06% |
| Dec. 18, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 27798 | $0.00 | 62,202.0000 | 42,058,821 | 30.89% | 0.07% |
| Dec. 19, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 14516 | $0.00 | 47,686.0000 | 42,058,821 | 23.34% | 0.03% |
| Dec. 20, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 26454 | $0.00 | 21,232.0000 | 42,058,821 | 55.48% | 0.06% |
| Dec. 18, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Common Stock | 27798 | $21.34 | 302,798.0000 | 42,058,821 | 10.11% | 0.07% |
| June 2, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 30272 | $21.58 | 276,000.0000 | 34,319,291 | 9.88% | 0.09% |
| June 2, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 1000 | $22.25 | 275,000.0000 | 34,319,291 | 0.36% | 0.00% |
| June 1, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 31272 | $22.09 | 306,272.0000 | 34,319,291 | 9.26% | 0.09% |
| May 31, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 31272 | $21.87 | 337,544.0000 | 34,319,291 | 8.48% | 0.09% |
| May 30, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 31271 | $21.90 | 368,816.0000 | 34,319,291 | 7.82% | 0.09% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | A | Common Stock | 137694 | $0.00 | 503,944.0000 | 33,582,202 | 37.60% | 0.41% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | F | Common Stock | 44121 | $26.75 | 459,823.0000 | 33,582,202 | 8.76% | 0.13% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | F | Common Stock | 59736 | $26.75 | 400,087.0000 | 33,582,202 | 12.99% | 0.18% |
| Feb. 13, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Common Stock | 11250 | $15.90 | 411,337.0000 | 33,582,202 | 2.81% | 0.03% |
| Feb. 13, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | S | Common Stock | 11250 | $26.88 | 400,087.0000 | 33,582,202 | 2.73% | 0.03% |
| Feb. 13, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | M | Stock Option (Right to Purchase) | 11250 | $0.00 | 0.0000 | 33,582,202 | 100.00% | 0.03% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Ciaffoni Joseph | President and CEO | A | Common Stock | 117500 | $0.00 | 366,250.0000 | 33,582,202 | 47.24% | 0.35% |